Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.06.2012 | short review | Ausgabe 2/2012

memo - Magazine of European Medical Oncology 2/2012

The role of biomarkers in the choice of therapy in breast cancer

Zeitschrift:
memo - Magazine of European Medical Oncology > Ausgabe 2/2012
Autoren:
MD Brigitte Mlineritsch, MD Sigrun Ressler, MD Prof. Richard Greil

Abstract

The discovery of prognostic and predictive biomarkers, enabling the application of more individualized therapies to different molecular breast cancer (BC) subtypes, has already led to changes in BC treatment during the past decades. In this review, the importance of established as well as of emerging biomarkers, currently undergoing testing for technical validity and clinical utility, is discussed.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 2/2012

memo - Magazine of European Medical Oncology 2/2012 Zur Ausgabe